Brett Goerl

Brett Goerl worked at Close Concerns and The diaTribe Foundation in 2021. He has a particular focus on covering therapeutic developments in ophthalmologic diseases associated with diabetes. Brett graduated from the University of Virginia with Highest Distinction and Phi Beta Kappa in 2020 with a degree in Human Biology. While at the University of Virginia, Brett published one of the first translational research projects to test acidic derivatives of cannabidiol (CBD) in animal models of epilepsy. Brett returned to the University of Virginia in Fall 2021 to pursue a dual MD/MBA degree, combining his passions for medicine and entrepreneurship. Outside of school, Brett is an avid film photographer and mixed-media artist, completing a fine arts fellowship at the Berlin Art Institute (DE) in the summer of 2022.